Search

Your search keyword '"Rossi, Davide"' showing total 1,150 results

Search Constraints

Start Over You searched for: Author "Rossi, Davide" Remove constraint Author: "Rossi, Davide" Publication Type Academic Journals Remove constraint Publication Type: Academic Journals
1,150 results on '"Rossi, Davide"'

Search Results

2. Early reappearance of intraclonal proliferative subpopulations in ibrutinib-resistant chronic lymphocytic leukemia

5. TOP: Towards Open & Predictable Heterogeneous SoCs

8. Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling

10. A leukemia-protective germline variant mediates chromatin module formation via transcription factor nucleation.

11. First-line venetoclax combinations versus chemoimmunotherapy in fit patients with chronic lymphocytic leukaemia (GAIA/CLL13): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial

12. Activity of venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia: analysis of the VENICE-1 multicentre, open-label, single-arm, phase 3b trial

13. Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY

17. Detection of early seeding of Richter transformation in chronic lymphocytic leukemia

18. Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma

19. SAKK 35/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphoma

20. Genetic and phenotypic attributes of splenic marginal zone lymphoma

23. Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA

24. Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendations

25. Circulating tumor DNA for comprehensive noninvasive monitoring of lymphoma treated with ibrutinib plus nivolumab

26. A multidisciplinary approach for the physic-chemical characterization of peloids to new perspectives in the development for 'hydrothermal Developing Countries' using partecipatory methodology

30. Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY

31. Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL

32. Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1

34. Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study

35. Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial

38. Copanlisib synergizes with conventional and targeted agents including venetoclax in B- and T-cell lymphoma models

41. COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus

42. HL-370 Fragmentóme Profiling Reveals Distinct Molecular Subgroups of Classic Hodgkin Lymphoma

44. Baseline circulating tumour DNA and interim PET predict response in relapsed/refractory classical Hodgkin lymphoma.

48. Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma

49. Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study

Catalog

Books, media, physical & digital resources